Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements

Radiology

Volumn 241, Issue 2, 2006, Pages 554-563

  Jennings, S Gregory ^a   Winer Muram, Helen T ^a   Tann, Mark ^a   Ying, Jun ^a   Dowdeswell, Ian ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFACT; CANCER GROWTH; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DATA ANALYSIS; DEVICE; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750380261     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2412051185     Document Type: Article

References (29)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111(6):1710-1717.
2. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96(3):440-447.
3. [Published correction appears in J Thorac Cardiovasc Surg 1989;97(3):350.]
4. Sone S, Takashime S, Li P, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351:1242-1245.
5. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
6. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
7. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: 5-year prospective experience. Radiology 2005;235:259-265.
8. Garland LH, Coulson W, Wollin E. The rate of growth and apparent duration of untreated primary bronchial carcinoma. Cancer 1963;16:694-701.
9. Spratt JS Jr, Spjut HJ, Roper CL. The frequency distribution of the rates of growth and the estimated duration of primary pulmonary carcinomas. Cancer 1963;16:687-693.
10. Steele JD, Buell P. Asymptomatic solitary pulmonary nodules, host survival, tumor size, and growth rate. J Thorac Cardiovasc Surg 1973;65:140-151.
11. Weiss W. Tumor doubling time and survival of men with bronchogenic carcinoma. Chest 1974;65:3-8.
12. Weiss W, Boucot KR, Cooper DA. Growth rate in the detection and prognosis of bronchogenic carcinoma. JAMA 1966;198:1246-1252.
13. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 2000;174:763-768.
14. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-1259.
15. Winer-Muram HT, Jennings SG, Tarver RD, et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 2002;223:798-805.
16. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest 2003;123(1 suppl):89S-96S.
17. Yankelevitz DF, Henschke CI. Does 2-year stability imply that pulmonary nodules are benign? AJR Am J Roentgenol 1997;168:325-328.
18. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CL. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217:251-256.
19. Yankelevitz DF, Gupta R, Zhao B, Henschke CI. Small pulmonary nodules: evaluation with repeat CT-preliminary experience. Radiology 1999;212:561-566.
20. Winer-Muram HT, Jennings SG, Meyer CA, et al. Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations. Radiology 2003;229:184-194.
21. Jennings SG, Winer-Muram HT, Tarver RD, Farber MO. Lung tumor growth assessment with CT: comparison of diameter and cross-sectional area with volume measurements. Radiology 2004;231:866-871.
22. Kostis WJ, Yankelevitz DF, Reeves AP, Fluture SC, Henschke CI. Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 2004;231:446-452.
23. Garland LH. The rate of growth and natural duration of primary bronchial cancer. Am J Roentgenol Radium Ther Nucl Med 1966;96:604-611.
24. Weiss W. Peripheral measurable bronchogenic carcinoma: growth rate and period of risk after therapy. Am Rev Respir Dis 1971;103:198-208.
25. Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1962;79:221-232.
26. Filderman AE, Shaw C, Matthay RA. Lung cancer in the elderly. Clin Geriatr Med 1986;2:363-383.
27. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-1068.
28. Libby DM, Smith JP, Altorki NK, Pasmantier MW, Yankelevitz D, Henschke CI. Managing the small pulmonary nodule discovered by CT. Chest 2004;125:1522-1529.
29. Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003;21:2574-2582.